1. Home
  2. NTCT vs ATAI Comparison

NTCT vs ATAI Comparison

Compare NTCT & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NetScout Systems Inc.

NTCT

NetScout Systems Inc.

HOLD

Current Price

$40.00

Market Cap

2.9B

Sector

Technology

ML Signal

HOLD

Logo ATAI Life Sciences N.V.

ATAI

ATAI Life Sciences N.V.

HOLD

Current Price

$7.18

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTCT
ATAI
Founded
1984
2018
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.6B
IPO Year
1999
2025

Fundamental Metrics

Financial Performance
Metric
NTCT
ATAI
Price
$40.00
$7.18
Analyst Decision
Buy
Strong Buy
Analyst Count
2
8
Target Price
$31.00
$15.88
AVG Volume (30 Days)
620.9K
19.6M
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
125.39
N/A
EPS
1.30
N/A
Revenue
$891,820,000.00
$4,089,000.00
Revenue This Year
$6.02
N/A
Revenue Next Year
$2.55
N/A
P/E Ratio
$30.35
N/A
Revenue Growth
N/A
1227.60
52 Week Low
$20.40
$3.06
52 Week High
$45.28
$7.22

Technical Indicators

Market Signals
Indicator
NTCT
ATAI
Relative Strength Index (RSI) 43.34 73.21
Support Level $38.72 $3.47
Resistance Level $40.92 N/A
Average True Range (ATR) 1.41 0.26
MACD -0.43 0.15
Stochastic Oscillator 11.51 97.95

Price Performance

Historical Comparison
NTCT
ATAI

About NTCT NetScout Systems Inc.

NetScout Systems Inc is engaged in providing enterprise network observability, carrier service assurance, cybersecurity, and Distributed Denial-of-Service (DDoS), protection solutions. It bases its solutions on proprietary adaptive service intelligence technology, which helps customers monitor and identify performance issues and provides insight into network-based security threats. These solutions also deliver real-time and historical information, which provides insight to restore service and understand the quality of user experience. The company derives revenue from the sale of network management tools and security solutions. Its geographical regions include USA, which derives maximum revenue, Europe, Asia, and Rest of the World.

About ATAI ATAI Life Sciences N.V.

AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD, and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.

Share on Social Networks: